XML 26 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Company’s Stockholders’ Equity
Total Company’s Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Class A
Common Stock
Class B-3
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income
Noncontrolling Interests in Investment Entities
Noncontrolling Interests in the Operating Partnership
Noncontrolling Interests in the Operating Partnership
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2018         83,410,000 44,399,000              
Beginning balance at Dec. 31, 2018 $ 2,845,202   $ 2,706,905   $ 834 $ 444 $ 2,899,353 $ (193,327)   $ (399) $ 72,683 $ 65,614  
Increase (Decrease) in Stockholders' Equity                          
Contributions 24                   24    
Distributions (394)                   (394)    
Conversion of Class B-3 common stock to Class A common stock (in shares)         44,399,000 (44,399,000)              
Conversion of Class B-3 common stock to Class A common stock         $ 444 $ (444)              
Issuance and amortization of equity-based compensation (in shares)         800,000                
Issuance and amortization of equity-based compensation 1,843   1,843   $ 8   1,835            
Other comprehensive income (loss) 13,843   13,519             13,519   324  
Dividends and distributions declared (57,066)   (55,726)         (55,726)       (1,340)  
Shares canceled for tax withholding on vested stock awards (in shares)         (96,000)                
Shares canceled for tax withholding on vested stock awards (1,497)   (1,497)   $ (1)   (1,496)            
Reallocation of equity     (23)       (23)         23  
Net income (loss) 14,957   14,908         14,908     (298) 347  
Ending balance (in shares) at Mar. 31, 2019         128,513,000 0              
Ending balance at Mar. 31, 2019 2,816,912   2,679,929   $ 1,285 $ 0 2,899,669 (234,145)   13,120 72,015 64,968  
Beginning balance (in shares) at Dec. 31, 2018         83,410,000 44,399,000              
Beginning balance at Dec. 31, 2018 2,845,202   2,706,905   $ 834 $ 444 2,899,353 (193,327)   (399) 72,683 65,614  
Increase (Decrease) in Stockholders' Equity                          
Conversion of Class B-3 common stock to Class A common stock 444                        
Other comprehensive income (loss) 26,567                        
Net income (loss) (95,833)                        
Ending balance (in shares) at Jun. 30, 2019         128,545,000 0              
Ending balance at Jun. 30, 2019 2,663,118   2,532,560   $ 1,285 $ 0 2,903,126 (397,398)   25,547 69,948 60,610  
Beginning balance (in shares) at Mar. 31, 2019         128,513,000 0              
Beginning balance at Mar. 31, 2019 2,816,912   2,679,929   $ 1,285 $ 0 2,899,669 (234,145)   13,120 72,015 64,968  
Increase (Decrease) in Stockholders' Equity                          
Contributions 11                   11    
Distributions (1,198)                   (1,198)    
Issuance and amortization of equity-based compensation (in shares)         32,000                
Issuance and amortization of equity-based compensation 2,713   2,713       2,713            
Other comprehensive income (loss) 12,724   12,427             12,427   297  
Dividends and distributions declared (57,254)   (55,912)         (55,912)       (1,342)  
Reallocation of equity     744       744         (744)  
Net income (loss) (110,790)   (107,341)         (107,341)     (880) (2,569)  
Ending balance (in shares) at Jun. 30, 2019         128,545,000 0              
Ending balance at Jun. 30, 2019 2,663,118   2,532,560   $ 1,285 $ 0 2,903,126 (397,398)   25,547 69,948 60,610  
Beginning balance (in shares) at Dec. 31, 2019         128,539,000 0              
Beginning balance at Dec. 31, 2019 2,201,350 $ (23,186) 2,119,022 $ (22,644) $ 1,285 $ 0 2,909,181 (819,738) $ (22,644) 28,294 31,631 50,697 $ (542)
Increase (Decrease) in Stockholders' Equity                          
Distributions (11,013)                   (11,013)    
Issuance and amortization of equity-based compensation 342   342       342            
Other comprehensive income (loss) (72,701)   (70,999)             (70,999)   (1,702)  
Dividends and distributions declared (39,463)   (38,541)         (38,541)       (922)  
Shares canceled for tax withholding on vested stock awards (in shares)         (173,000)                
Shares canceled for tax withholding on vested stock awards (1,687)   (1,687)   $ (1)   (1,686)            
Reallocation of equity     (41)       (41)         41  
Net income (loss) (80,141)   (78,772)         (78,772)     523 (1,892)  
Ending balance (in shares) at Mar. 31, 2020         128,366,000 0              
Ending balance at Mar. 31, 2020 1,973,501   1,906,680   $ 1,284 $ 0 2,907,796 (959,695)   (42,705) 21,141 45,680  
Beginning balance (in shares) at Dec. 31, 2019         128,539,000 0              
Beginning balance at Dec. 31, 2019 2,201,350 $ (23,186) 2,119,022 $ (22,644) $ 1,285 $ 0 2,909,181 (819,738) $ (22,644) 28,294 31,631 50,697 $ (542)
Increase (Decrease) in Stockholders' Equity                          
Conversion of Class B-3 common stock to Class A common stock 0                        
Other comprehensive income (loss) (3,094)                        
Net income (loss) (320,725)                        
Ending balance (in shares) at Jun. 30, 2020         128,583,000 0              
Ending balance at Jun. 30, 2020 2,000,837   1,679,907   $ 1,286 $ 0 2,840,134 (1,186,754)   25,241 281,041 39,889  
Beginning balance (in shares) at Mar. 31, 2020         128,366,000 0              
Beginning balance at Mar. 31, 2020 1,973,501   1,906,680   $ 1,284 $ 0 2,907,796 (959,695)   (42,705) 21,141 45,680  
Increase (Decrease) in Stockholders' Equity                          
Contributions 200,467                   200,467    
Distributions (3,156)                   (3,156)    
Issuance and amortization of equity-based compensation (in shares)         237,000                
Issuance and amortization of equity-based compensation 1,549   1,549   $ 2   1,547            
Other comprehensive income (loss) 69,607   67,946             67,946 257 1,404  
Shares canceled for tax withholding on vested stock awards (in shares)         (20,000)                
Shares canceled for tax withholding on vested stock awards (81)   (81)       (81)            
Reallocation of equity     1,777       1,777         (1,777)  
Costs of noncontrolling equity (466)   (466)       (466)            
Investment by JV partner in consolidated JV and equity reallocation related to that partner’s return (see Note 2)     (70,439)       (70,439)       70,439    
Net income (loss) (240,584)   (227,059)         (227,059)     (8,107) (5,418)  
Ending balance (in shares) at Jun. 30, 2020         128,583,000 0              
Ending balance at Jun. 30, 2020 $ 2,000,837   $ 1,679,907   $ 1,286 $ 0 $ 2,840,134 $ (1,186,754)   $ 25,241 $ 281,041 $ 39,889